Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotics for Outpatient Urethral Bulking
NCT07501065Phase 4Recruiting
- Sponsor
- University of Miami
- Start
- Aug 2026
- Primary completion
- Jun 2028
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trimethoprim + sulfamethoxazole, cefalexin, ciprofloxacin and nitrofurantoin in urinary tract infection (UTI) (2 arms), sponsored by University of Miami. Primary endpoint: Incidence of post-procedural urinary tract infection at 6 weeks. Started Aug 2026; status: recruiting.
02
Drugs
trimethoprim + sulfamethoxazolecefalexinciprofloxacinnitrofurantoin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07501065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07501065.